MedTrace Logo

Assessing the Impact of COVID-19 on HMPV Incidence and Severity Among Adults

NCT06309212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2197

Last updated 2024-03-13

No results posted yet for this study

Summary

Human metapneumovirus (HMPV) is primarily recognized as a childhood pathogen, but its impact on adults remains largely underestimated. This study investigates the prevalence, clinical characteristics, and post-COVID-19 trends of HMPV infection among adults in Istanbul, Turkey.

Conditions

  • The Prevalance of HMPV After COVID-19 Pandemic
  • The Importance of Accurate Diagnosis for HPMV

Interventions

OTHER

Observation

Analyse of data from adults with respiratory tract infections who were tested for various respiratory viruses using a multiplex PCR assay

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2023-12-30
Completion
2024-01-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06309212 on ClinicalTrials.gov